Felix F, Brouillet N
Laboratoire de Biochimie des Porphyrines, Institut Jacques Monod, Université Paris 7, France.
Eur J Biochem. 1990 Mar 10;188(2):393-403. doi: 10.1111/j.1432-1033.1990.tb15416.x.
Uroporphyrinogen decarboxylase (EC 4.1.1.37) was purified about 14000-fold to homogeneity from the yeast Saccharomyces cerevisiae with a 70% overall yield. The purification included affinity chromatography on uroporphyrin-I-Affi-Gel 102. The specific activity of the final preparation was 1750 nmol coproporphyrinogen formed.h-1.(mg protein)-1 at pH 7.5 and 37 degrees C using 4 microM uroporphyrinogen I as substrate. The purified enzyme has a minimum molecular mass of 38 kDa by sodium dodecyl sulfate/polyacrylamide gel electrophoresis and 46 kDa by gel filtration, suggesting that yeast uroporphyrinogen decarboxylase is a monomer. Chromatofocusing gave a pI of 6.0. Enzyme activity was inhibited by metals, such as Cu2+, Zn2+, Fe2+, Fe3+ and by sulfhydryl-specific reagents, but no cofactor requirement could be demonstrated. The optimum pH was pH 5.7 for uroporphyrinogens I and III and heptacarboxylate porphyrinogen I as estimated by coproporphyrinogen formation. The optimum pH for substrate decarboxylation was pH 5.7 for uroporphyrinogen I, but pH 6.8 for the two other substrates. The Km values at pH 5.7 were 10 nM for uroporphyrinogen I, 6 nM for uroporphyrinogen III and 7 nM for heptacarboxylate porphyrinogen I as measured by coproporphyrinogen formation. The pattern of accumulation of intermediate and final decarboxylation products and the rates of the successive decarboxylations were determined for the three substrates at different concentrations at pH 5.7 and pH 6.8. The rate-limiting step at 4 microM substrate concentration was the elimination of the second carboxyl group of uroporphyrinogen III and the fourth carboxyl of uroporphyrinogen I. An antiserum to purified yeast uroporphyrinogen decarboxylase was used to characterize the protein in several mutants.
从酿酒酵母中纯化出尿卟啉原脱羧酶(EC 4.1.1.37),纯化倍数约为14000倍,达到同质,总产率为70%。纯化过程包括在尿卟啉-I-Affi-Gel 102上进行亲和层析。最终制剂的比活性在pH 7.5和37℃下,以4μM尿卟啉原I为底物时为1750 nmol粪卟啉原形成·h⁻¹·(mg蛋白质)⁻¹。通过十二烷基硫酸钠/聚丙烯酰胺凝胶电泳,纯化酶的最小分子量为38 kDa,通过凝胶过滤为46 kDa,这表明酵母尿卟啉原脱羧酶是一种单体。层析聚焦法测得其pI为6.0。酶活性受到金属如Cu²⁺、Zn²⁺、Fe²⁺、Fe³⁺以及巯基特异性试剂的抑制,但未证明有辅因子需求。通过粪卟啉原形成估计,尿卟啉原I、III和七羧基卟啉原I的最适pH为5.7。尿卟啉原I底物脱羧的最适pH为5.7,但其他两种底物为6.8。在pH 5.7时,尿卟啉原I的Km值为10 nM,尿卟啉原III为6 nM,七羧基卟啉原I为7 nM,通过粪卟啉原形成测定。在pH 5.7和pH 6.8下,测定了三种底物在不同浓度时中间和最终脱羧产物的积累模式以及连续脱羧的速率。在4μM底物浓度下,限速步骤是尿卟啉原III的第二个羧基和尿卟啉原I的第四个羧基的消除。用针对纯化的酵母尿卟啉原脱羧酶的抗血清对几个突变体中的该蛋白质进行了表征。